ZiamoX-625
Home >> Products >> Ziamox-625
Ziamox-625
ZiamoX-625 Tablet is a broad-spectrum antibiotic combination containing Amoxycillin and Potassium Clavulanate. It is effective against a wide range of bacterial infections by inhibiting bacterial cell wall synthesis and overcoming resistance caused by beta-lactamase producing organisms.
Each film-coated tablet contains:
- Amoxycillin Trihydrate I.P.
Equivalent to Amoxycillin — 500 mg - Potassium Clavulanate Diluted I.P.
Equivalent to Clavulanic Acid — 125 mg - Excipients: q.s.
- Colour: Titanium Dioxide I.P
- Upper and lower respiratory tract infections
- Ear, nose & throat (ENT) infections
- Urinary tract infections
- Skin and soft tissue infections
- Dental infections
- Bone and joint infections
- Other infections caused by susceptible bacteria
As directed by the physician.
Medicine Production Process
01
Research & Development (R&D)
New drug molecules are discovered, tested, and optimized for safety, efficacy, and stability.
02
Pre-Formulation Studies
Understanding the drug’s physical, chemical, and biological properties to design the right dosage form.
03
Formulation Development
Creating the final dosage form (tablet, capsule, injection, etc.) with excipients to ensure effectiveness.
04
Raw Material Procurement
High-quality active pharmaceutical ingredients (APIs) and excipients are sourced under strict compliance.
05
Weighing & Dispensing
Precise measurement of raw materials to maintain consistency and quality in every batch.
06
Granulation / Mixing
APIs and excipients are blended or granulated to achieve uniformity for tablet or capsule production.
07
Compression / Filling
The mixture is compressed into tablets or filled into capsules with accuracy.
08
Coating / Finishing
Tablets may be coated for taste masking, controlled release, or product stability.
09
Sterilization (for Injectables)
Parenteral products undergo sterilization to ensure they are safe and free from contaminants.
10
Quality Control (QC) Testing
Each batch is rigorously tested for purity, potency, safety, and compliance with regulatory standards.
11
Packaging
Medicines are packed in blisters, bottles, or sachets with labeling and batch details for traceability.
12
Storage & Distribution
Finished products are stored under controlled conditions and distributed through the pharma supply chain.
